Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ACROBiosystems

ACROBiosystems
2010 FOUNDED
PRIVATE STATUS
101-200 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
4 INVESTORS
Description

Manufacturer of recombinant proteins intended to support cancer immunotherapy. The company's product includes immune checkpoint proteins, targets of car-t cell therapy, biosimilar drug targets, biotinylated protein collection enzymes and antibodies, enabling biopharma clients to facilitate the quantitative analysis of therapeutic antibodies in serum samples and inhibitor screening kits.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • Floor 4, Building 5
  • 8 Hongda North Road, BDA
  • Beijing, 100176
  • China

+86 010 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ACROBiosystems’s full profile, request a free trial.

ACROBiosystems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC Completed Generating Revenue
1. Accelerator/Incubator 19-Jan-2018 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

ACROBiosystems Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Delaware Technology Park Other Minority 000 0000 000000 0
Cowin Capital Venture Capital Minority 000 0000 000000 0
Neovision Capital Venture Capital Minority 000 0000 000000 0
Puhua Capital Venture Capital Minority 000 0000 000000 0

ACROBiosystems Executive Team (1)

Name Title Board
Seat
Contact
Info
Yiding Chen Founder, Chairman, President, Chief Executive Officer & Chief Financial Officer